SEI Investments’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
AIM
VPM
VCM
MCMU
SEI Investments's RXRX Position: Q1 2026 in Review
SEI Investments reduced its Recursion Pharmaceuticals (RXRX) stake by 0.15% in Q1 2026, selling an estimated $298 and leaving 50,448 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #3020.
SEI Investments first reported a position in RXRX in Q3 2024 and has held it in 7 quarters since. The position peaked at $247K in Q3 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.
- SEI Investments held 50,448 shares of Recursion Pharmaceuticals worth $155K as of Q1 2026.
- SEI Investments sold 77 Recursion Pharmaceuticals shares in Q1 2026, an estimated $298.
- Recursion Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3020 holding.
- SEI Investments first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
- SEI Investments's Recursion Pharmaceuticals position peaked at $247K in Q3 2025.
- 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.